The 2G_PROVEIL project is developing antimicrobial nanofiber-based high-efficiency filters to deliver robust protection against viruses, bacteria, and particulate matter—combining maximum filtration capacity with excellent breathability, ergonomic fit, and superior comfort. The research focuses on optimizing filtration performance, pressure drop, wearer comfort, fit, reusability, and long-term durability, ensuring the highest level of protection without compromising usability.
The project will evaluate the integration of sensors to detect potential seal leaks, helping to improve user safety. This approach seeks to provide reliable fit verification and reduce the risk of exposure in high-risk environments
2G_PROVEIL is a European research initiative developing a second generation of reusable face masks based on electrospun antimicrobial nanofibers. The goal is to improve fit, safety, and sustainability, creating a high-performance solution fully developed in Europe. The project will work closely with scientific and technological partners to validate the design and assess its performance in real-world settings, contributing to better preparedness for future public health challenges.
2G_PROVEIL is a European Union–funded innovation project exploring the development of next-generation reusable face masks with advanced nanofiber-based filtration for enhanced respiratory protection. The project aims to combine high-performance nanofiber technology, user-safe materials, and innovative fit-detection sensors, targeting compliance with FFP2 and FFP3 certification standards.
Going beyond traditional protective equipment, 2G_PROVEIL seeks to pave the way for a new era of intelligent protection — masks designed to adapt to the user’s needs, improving comfort and safety during prolonged use in both healthcare settings and everyday life.
Develop breakthrough antimicrobial nanofiber technology with electret-free filters that maintain high performance in humid conditions while ensuring reusability and prolonged self-life during storing.
Integrate intelligent fit-detection sensors and IoT connectivity to create the world’s first smart PPE masks that actively monitor protection effectiveness in real-time.
Develop breakthrough antimicrobial nanofiber technology with electret-free filters that maintain high performance in humid conditions while ensuring reusability and prolonged self-life during storing.
Scale up production capabilities and achieve CE certification for FFP2 and FFP3 standards, bringing European-made advanced PPE solutions to global markets.
Built-in sensors monitor seal and fit in real time
Alerts via connected device or mobile app
Antimicrobial nanofiber filters with high breathability
Easy disinfection with alcohol-water sprays
FFP2: ≥94% filtration efficiency
FFP3: ≥99% filtration efficiency
EU4Health is the EU’s largest health programme in monetary terms. The EU4Health programme goes beyond an ambitious response to the COVID-19 crisis to address the resilience of European healthcare systems. EU4Health provides funding to national authorities, health organisations and other bodies through grants and public procurement, contributing to a healthier Europe.
Work programmes: EU4Health is implemented by annual Work Programmes supporting a broad range of actions that are clustered under four overarching “strands” with a cross-cutting focus on cancer:
The programme provides funding to eligible entities, health organisations and NGOs from EU countries, or non-EU countries associated to the programme.
WP1 – Project Management and IPR | Coordination, quality control, risk management, and IP protection for reusable FFP2 and FFP3 mask development. | M1-M48
10%
WP2 – Material Selection and PPE’s Filter Development | M1-M12
41%
Call: EU4H-2024-PJ-01
Type of Action: EU4H-PJG
Acronym: 2G_PROVEIL
GA: 101203379
Duration: 48 months
Project start date: 1st April 2025
Project ending date: 31st March 2029
Estimated Project Cost: €5,144,630.37
Requested EU Contribution: €4,115,704.30
Project co-funded under the EU4Health Programme 2021–2027 under grant agreement no. 101203379. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
